218 related articles for article (PubMed ID: 33683652)
1. Utility of novel T-cell-specific extracellular vesicles in monitoring and evaluation of acute GVHD.
Nagasawa M; Mitsuiki N; Yanagimachi M; Yamamoto M; Fukuda T; Miura O; Oba R; Igarashi A; Nagata K; Morio T
Int J Hematol; 2021 Jun; 113(6):910-920. PubMed ID: 33683652
[TBL] [Abstract][Full Text] [Related]
2. Circulating CD3
Oba R; Isomura M; Igarashi A; Nagata K
J Immunol Res; 2019; 2019():6720819. PubMed ID: 31205958
[TBL] [Abstract][Full Text] [Related]
3. Frequency of HLA-DR
Nguyen TH; Kumar D; Prince C; Martini D; Grunwell JR; Lawrence T; Whitely T; Chappelle K; Chonat S; Prahalad S; Briones M; Chandrakasan S
J Allergy Clin Immunol; 2024 Jan; 153(1):309-319. PubMed ID: 37517575
[TBL] [Abstract][Full Text] [Related]
4. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
5. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
6. Expression of activation-related molecules on regional lymph node lymphocytes in human lung cancer.
Takenoyama M; Yasumoto K; Harada M; Matsuzaki G; Ishida T; Sugimachi K; Nomoto K
Immunobiology; 1996 Jul; 195(2):140-51. PubMed ID: 8877391
[TBL] [Abstract][Full Text] [Related]
7. [Lymphocyte activation markers in patients with ovarian cancer].
Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
[TBL] [Abstract][Full Text] [Related]
8. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
[TBL] [Abstract][Full Text] [Related]
9. Prediction of graft-versus-host disease: a biomarker panel based on lymphocytes and cytokines.
Budde H; Papert S; Maas JH; Reichardt HM; Wulf G; Hasenkamp J; Riggert J; Legler TJ
Ann Hematol; 2017 Jul; 96(7):1127-1133. PubMed ID: 28447161
[TBL] [Abstract][Full Text] [Related]
10. The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions.
Mutis T; Aarts-Riemens T; Verdonck LF
Haematologica; 2005 Oct; 90(10):1389-95. PubMed ID: 16219576
[TBL] [Abstract][Full Text] [Related]
11. Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations.
Fujii S; Miura Y; Fujishiro A; Shindo T; Shimazu Y; Hirai H; Tahara H; Takaori-Kondo A; Ichinohe T; Maekawa T
Stem Cells; 2018 Mar; 36(3):434-445. PubMed ID: 29239062
[TBL] [Abstract][Full Text] [Related]
12. Immune microenvironment associated with the severity of Langerhans cell histiocytosis in children.
Cai F; Peng Z; Xu H; Gao H; Liao C; Xu X; Guo X; Gu W; Zhu K; Shu Q; Shen H
Cytokine; 2023 Nov; 171():156378. PubMed ID: 37748334
[TBL] [Abstract][Full Text] [Related]
13. CD38
Khandelwal P; Chaturvedi V; Owsley E; Lane A; Heyenbruch D; Lutzko CM; Leemhuis T; Grimley MS; Nelson AS; Davies SM; Jordan MB; Marsh RA
Biol Blood Marrow Transplant; 2020 Jan; 26(1):1-6. PubMed ID: 31442594
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
Körbling M; Huh YO; Durett A; Mirza N; Miller P; Engel H; Anderlini P; van Besien K; Andreeff M; Przepiorka D; Deisseroth AB; Champlin RE
Blood; 1995 Oct; 86(7):2842-8. PubMed ID: 7545476
[TBL] [Abstract][Full Text] [Related]
15. Expression of interleukin-2 receptor by activated peripheral blood lymphocytes upregulated by the plasma level of interleukin-2 in patients with recurrent aphthous ulcers.
Sun A; Chu CT; Liu BY; Wang JT; Leu JS; Chiang CP
Proc Natl Sci Counc Repub China B; 2000 Jul; 24(3):116-22. PubMed ID: 10943944
[TBL] [Abstract][Full Text] [Related]
16. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
[TBL] [Abstract][Full Text] [Related]
17. CD161(+) T cells as predictive markers for acute graft-versus-host disease.
Lee SE; Lim JY; Yoon JH; Shin SH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Min CK
Biol Blood Marrow Transplant; 2015 Mar; 21(3):421-8. PubMed ID: 25543092
[TBL] [Abstract][Full Text] [Related]
18. CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-alpha, IFN-gamma, and sIL-2R levels in aging.
Rea IM; McNerlan SE; Alexander HD
Exp Gerontol; 1999 Jan; 34(1):79-93. PubMed ID: 10197730
[TBL] [Abstract][Full Text] [Related]
19. [Clinical Significance of Monitoring T Lymphocyte Subsets after Allogeneic Hematopoietic Stem Cell Transplantation].
Tong C; Guo Z; Lou JX; Liu XD; Yang K; He XP; Chen P; Zhang Y; Chen HR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):167-72. PubMed ID: 26913415
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
